‡a
Author's Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia.
‡a
Author's AEE788 is a vascular endothelial growth factor receptor tyrosine kinase inhibitor with antiproliferative and proapoptotic effects in acute myeloid leukemia.
‡a
additiveeffectofptk787zk222584apotentinhibitorofvegfrphosphorylationwithidarubicininthetreatmentofacutemyeloidleukemia
‡A
Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia.
‡9
1
‡a
aee788isavascularendothelialgrowthfactorreceptortyrosinekinaseinhibitorwithantiproliferativeandproapoptoticeffectsinacutemyeloidleukemia
‡A
AEE788 is a vascular endothelial growth factor receptor tyrosine kinase inhibitor with antiproliferative and proapoptotic effects in acute myeloid leukemia.
‡9
1